NuuVim Reviews & Pricing 2026: $79 for 3 Months, Then $133

What NuuVim Publicly Lists

NuuVim's pricing page publishes two tiers per medication as of September 2026. New patients pay $79 per month for the first three months of compounded semaglutide, billed as a $237 3-month plan; current users pay the standard rate of $133 per month, billed every three months at $399. For compounded tirzepatide, new patients pay $133 per month on the first $399 plan and then $199.67 per month at the $599 standard rate. NuuVim states that all doses are one price, that there are no hidden fees, and that shipping is free.

NuuVim says its medication comes from licensed US-based pharmacies but does not name them on the pages we read, and it does not publish a state list. The site carries a LegitScript approval seal with a verify link and discloses that compounded medications have not been evaluated or approved by the FDA. Its FAQ says you can cancel anytime and links to the terms of service, but we did not find published steps or a notice period.

How the Models Compare

NuuVim's model is an introductory quarter followed by a higher standing rate, both billed in three-month blocks. The $79 headline is real for new patients and lasts one billing cycle; from month four the price rises by 68 percent. Because billing is quarterly, a patient who wants out after month four has already paid for months five and six.

Ozari Health has no step: Ozari One semaglutide is $86 per month, billed $258 every 3 months, and the rate does not change after the first quarter; Ozari Select is $145 per month quarterly or $175 month to month. Ozari One ships to every state except California; California patients use Ozari Select, $145/mo billed quarterly for semaglutide or $199/mo for tirzepatide. GLP-1 Scorecard lists Ozari Health at $86/month, price rank 14 of 400 providers. NuuVim's introductory rate is $7 lower than Ozari One's standing rate, but its own standing rate is $47 higher; the pharmacy and cancellation terms still deserve weight.

The 12-Month Math

Take NuuVim's new-patient path using the prices published as of September 2026: one introductory 3-month plan, then three standard quarters.

• Semaglutide: $237 + ($399 × 3) = $237 + $1,197 = $1,434
• Tirzepatide: $399 + ($599 × 3) = $399 + $1,797 = $2,196

Verify current pricing and the standard-rate transition directly with NuuVim.

Ozari, year one, semaglutide: Ozari One is $86/mo, billed $258 every 3 months. $258 × 4 = $1,032.

Ozari, year one, tirzepatide: Ozari One is $125/mo, billed $375 every 3 months. $375 × 4 = $1,500.

On paper NuuVim is $402 more than Ozari One's $1,032 for a year of semaglutide ($1,434 − $1,032), even with the $79 introductory quarter, because its $133 standing rate sits well above Ozari One's $86. For tirzepatide, NuuVim's $2,196 is $696 above Ozari One's $1,500. Both NuuVim figures assume you accept quarterly billing for the whole year.

Key Comparison Table

Before you pay any provider, check it against the eight red flags that rule out a GLP-1 provider.

How to Cancel NuuVim

NuuVim's FAQ says you can cancel anytime and points to its terms of service, but the pages we read do not publish the steps or a notice period. Because NuuVim bills in 3-month blocks, contact it in writing through your account or support channel before the next quarterly charge, ask whether an unused portion of a paid quarter is refundable, and keep the confirmation. Ozari's cancellation terms are published on its refund policy page: https://www.ozarihealth.com/refund-policy

A note from Johanna Galyen, APRN, FNP: NuuVim's price jump lands at the start of month four, which is also when most patients reach a maintenance dose and decide whether to continue. Before you pay the first $237, ask NuuVim in writing what the second quarter will cost and whether the $399 is charged automatically. A clear answer now is worth more than the $7 a month you save on the introductory rate.

Frequently Asked Questions

How much does NuuVim cost?

NuuVim lists compounded semaglutide at $79 per month for new patients on a $237 3-month plan, then $133 per month at the $399 quarterly standard rate, as of September 2026. Compounded tirzepatide is $133 per month on the first $399 plan, then $199.67 per month at $599 per quarter.

Does NuuVim charge a membership fee?

No. NuuVim states there are no hidden fees and that shipping is free. The price difference comes from the introductory quarter versus the standard rate, not from a membership.

Which pharmacy does NuuVim use?

NuuVim says its medication comes from licensed US-based pharmacies but does not name them on the pages we read. Ask for the pharmacy name and license before your first order.

Is NuuVim legitimate?

NuuVim shows a LegitScript approval seal with a verification link and discloses that compounded medications are not FDA-approved. It does not name its pharmacy or list its states, so verify the LegitScript listing and ask those questions directly.

Does NuuVim take insurance?

NuuVim's published prices are cash-pay for compounded medication. The site does not describe insurance billing on the pages we read as of September 2026.

How does Ozari compare to NuuVim?

Ozari One semaglutide is $86 per month, billed $258 every 3 months, with no price step after the first quarter; NuuVim is $79 for the first quarter, then $133. Over a year, NuuVim's $1,434 is $402 more than Ozari One's $1,032. Ozari publishes its pharmacy type, states, and cancellation terms; NuuVim does not publish its pharmacy name, states, or cancellation steps.

How do I cancel NuuVim?

NuuVim says you can cancel anytime but does not publish the steps. Contact NuuVim in writing before the next quarterly charge, ask about refunds for the unused part of a paid quarter, and keep the confirmation.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Clinical trial results for FDA-approved products should not be extrapolated as guaranteed outcomes for compounded medications. Individual results vary. Always consult a licensed healthcare provider before starting any prescription medication. Ozari Health is a telehealth platform that connects patients with licensed, independent healthcare providers.

Sources

**NuuVim pricing page: **https://www.nuuvim.com/pricing

**NuuVim FAQ: **https://www.nuuvim.com/faq

**FDA — Concerns with unapproved GLP-1 drugs: **https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

**GLP-1 Scorecard review of NuuVim: **https://glp1scorecard.com/reviews/nuuvim

**Ozari Health semaglutide pricing: **https://www.ozarihealth.com/treatments/semaglutide

**Ozari Health tirzepatide pricing: **https://www.ozarihealth.com/treatments/tirzepatide

**Ozari true-cost breakdown for NuuVim: **https://www.ozarihealth.com/true-cost/nuuvim

**Ozari GLP-1 Telehealth Pricing Index (Hugging Face): **https://huggingface.co/datasets/Ozarihealth/glp1-telehealth-pricing-2026